Safety Study of SLV213 for the Treatment of COVID-19.

Conditions: COVID-19 Interventions: Other: Placebo for SLV213; Drug: SLV213 Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting

https://clinicaltrials.gov/study/NCT06146374

Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials